Caro Holdings (CAHO) Research & Development (2023 - 2025)
Quarterly results put Research & Development at $404.0 for Q3 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $1298.0 (up 134.72% YoY), and the annual figure for FY2025 was $494.0, down 99.62%.
Caro Holdings has reported Research & Development over the past 3 years, most recently at $404.0 for Q3 2025.
- Research & Development reached $404.0 in Q3 2025 per CAHO's latest filing, up from $400.0 in the prior quarter.
- Across five years, Research & Development topped out at $103001.0 in Q1 2023 and bottomed at $400.0 in Q2 2025.
- Median Research & Development over the past 3 years was $9716.0 (2023), compared with a mean of $29324.0.
- The largest annual shift saw Research & Development tumbled 99.46% in 2024 before it dropped 10.67% in 2025.
- Over 3 years, Research & Development stood at $18879.0 in 2023, then plummeted by 97.07% to $553.0 in 2024, then fell by 26.94% to $404.0 in 2025.
- Business Quant data shows Research & Development for CAHO at $404.0 in Q3 2025, $400.0 in Q2 2025, and $494.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Relx | 81.40 Bn | 81.16 Bn | - | - |
| 2 | Rentokil Initial | 79.56 Bn | 78.10 Bn | - | - |
| 3 | Cintas | 69.26 Bn | 69.08 Bn | 1.45 Bn | - |
| 4 | Copart | 33.09 Bn | 28.01 Bn | 971.24 Mn | - |
| 5 | UL Solutions | 20.56 Bn | 20.32 Bn | 381.00 Mn | - |
| 6 | Global Payments | 19.88 Bn | 14.69 Bn | 1.70 Bn | - |
| 7 | Rb Global | 19.08 Bn | 18.89 Bn | 869.50 Mn | - |
| 8 | Aramark | 13.57 Bn | 13.16 Bn | 426.35 Mn | - |
| 9 | Amentum Holdings | 5.65 Bn | 5.74 Bn | 345.00 Mn | - |
| 10 | Caro Holdings | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 404.00 |
| Jun 30, 2025 | 400.00 |
| Mar 31, 2025 | 494.00 |
| Mar 31, 2024 | 553.00 |
| Dec 31, 2023 | 18,879.00 |
| Sep 30, 2023 | 47,207.00 |
| Jun 30, 2023 | 63,654.00 |
| Mar 31, 2023 | 103,001.00 |